Recently, Zhang et al. identified six genes, including ALDH6A1, as biomarkers for ccRCC, and demonstrated that downregulation of the ALDH6A1 gene was associated with shorter overall survival of ccRCC patients in the TCGA dataset [34]. Here, ALDH6A1 is linked to nonpapillary renal cell carcinoma.